MFDS — authorised 20 April 2000
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇰🇷 Lantus in South Korea
MFDS authorised Lantus on 20 April 2000
Marketing authorisation
Lantus in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Lantus approved in South Korea?
Yes. MFDS authorised it on 20 April 2000.
Who is the marketing authorisation holder for Lantus in South Korea?
SANOFI AVENTIS US holds the South Korean marketing authorisation.